DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ArQule, Inc. (ARQL)
« Back to company indexARQL Chatter Timeline
Stock Ticker for ARQL
Most Active Tweeters for ARQL
| User | Tweets |
|---|---|
| @Gambiste1 | 19 |
| @1MinuteStock | 13 |
| @Tickeron | 6 |
| @MC_OptionTrades | 5 |
| @portefeuillefun | 5 |
Recent Tweets for ARQL
 |
@TopStockAlerts1 $ARQL Likes to move fast! June 17th 2019, 10:06pm |
 |
@1MinuteStock We calculated 63-day Expected Return of $ARQL for you: 91.86% https://t.co/YmpgXynHlw June 17th 2019, 10:06pm |
 |
@RoboSchmobo The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs https://t.co/PMLkeVOCWz $ARQL… https://t.co/fyzsax4UoM June 17th 2019, 10:06pm |
|
@1MinuteStock Wondering about risks of $ARQL? The 63-day volatility is 43.65% https://t.co/V5eI2IPSw1 June 17th 2019, 9:06pm |
 |
@tzack16 The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs https://t.co/w6aJ4CAgUx $ARQL… https://t.co/2iRSPEfL0W June 17th 2019, 8:06pm |
 |
@Rbmetzger @volition202020 Or make money it seems. $ARQL in same arena as ARRY As well as PCYC and LOXO. Look those up June 17th 2019, 8:06pm |
 |
@trade_to_profit $ARQL nice one .. congrats https://t.co/2SYkR9zW6S June 17th 2019, 8:06pm |
 |
@RickyAnalog_STN You know what’s worse that being flat $ARQL overnight in order to not get caught in a financing? Being short overn… https://t.co/5aRsTv0dag June 17th 2019, 7:06pm |
 |
@Easy_Money_weee $ARQL none stop even after hours hit $10.3. June 17th 2019, 7:06pm |
 |
@nawkker @THETECHNICIAN84 Yea somehow missed that short too. Was short $ARQL, but that went nowhere and had to cut it. June 17th 2019, 6:06pm |
 |
@TheTomStouffer $ARQL still has room to grow upward but quickly entering into overbought territory June 17th 2019, 6:06pm |
 |
@volition202020 $ARQL - Financials are a disaster. Revenues declined by over 200% in Q1. ? 10.3 mil NET LOSS +58% INCREASE (prior… https://t.co/TvtrKszVP9 June 17th 2019, 6:06pm |
 |
@thismamatweets ArQule Hits 12-Year High Following Favorable Midstage Study Results $ARQL https://t.co/5iTEJ7c4P0 # via @benzinga June 17th 2019, 6:06pm |
|
@TopStockAlerts1 $ARQL Liking it for a swing!!! June 17th 2019, 6:06pm |
 |
@risk_averse_ The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs https://t.co/Q8X3Uvnzlq $ARQL… https://t.co/bCPCwM2H7V June 17th 2019, 6:06pm |
 |
@bullriders1 $ARQL +6% $10.15 AH round-three June 17th 2019, 5:06pm |
 |
@moshakes_911 $ARQL shorts taking some ass whipping AH https://t.co/LSKn7zlNOd June 17th 2019, 5:06pm |
 |
@jfais20 $ARQL our current trade summary from ROTY https://t.co/70Lf7l7ydr June 17th 2019, 5:06pm |
 |
@ST4R_L0RD_ $ARQL are you kidding me June 17th 2019, 5:06pm |
|
@volition202020 $arql pump and dump setup June 17th 2019, 5:06pm |
 |
@rajramaswamy RT @InvestorsLive: $ARQL over $10 now 10:11:07 am InvestorsLive: ARQL this could be 10-12 later if it wants June 17th 2019, 5:06pm |
 |
@InvestorsLive $ARQL over $10 now 10:11:07 am InvestorsLive: ARQL this could be 10-12 later if it wants June 17th 2019, 5:06pm |
|
@nawkker $ARQL scratch per plan https://t.co/Sk5qGtyKRu June 17th 2019, 5:06pm |
|
@InvestorsLive $ARQL nearing $10 AHs Nice continuation June 17th 2019, 5:06pm |
 |
@invesTakeCharge Watching $ARQL $CLCI tomorrow morning. June 17th 2019, 4:06pm |
 |
@Soapylever5000 $ARQL never seen so much excitement on a phase 1 trial. Lol.. folks even talking buyout June 17th 2019, 4:06pm |
 |
@Kittizens The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs https://t.co/H4w3znS5gu $ARQL… https://t.co/edfsW6iCSg June 17th 2019, 4:06pm |
 |
@DowDog2018 The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs https://t.co/DQnEfbs9be $ARQL… https://t.co/eSvyRCS3Wn June 17th 2019, 4:06pm |
 |
@portefeuillefun RT @semodough: Roth $ARQL Buy, $20.00 PT, Target Price Change, From 13 EHA meeting, ArQule presented updated data from its first-in-huma… June 17th 2019, 4:06pm |
 |
@MarketChmln $ARQL $ARQL #ArquleInc. gains in after hours trading. See vwap price action. https://t.co/UTsAoze2L6 https://t.co/HecbP6EFlE June 17th 2019, 4:06pm |
|
@1MinuteStock Wondering about risks of $ARQL? The 21-day volatility is 36.2% https://t.co/V5eI2IPSw1 June 16th 2019, 11:06pm |
 |
@TheUnicornBay Unicorn Bay rating for $ARQL is 1.56 out of 5. https://t.co/c9AycsEYql June 16th 2019, 10:06pm |
 |
@Biohazard3737 @BiotEddie @JacobPlieth Look at # of prior therapies. $ARQL enrolled patients with 4 or less prior lines of therapy… https://t.co/Dm1t4SHNOl June 16th 2019, 10:06pm |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $ARQL is $-0.11 it's -1.34% of the current price https://t.co/xbKbhcl53K June 16th 2019, 8:06pm |
|
@1MinuteStock Wondering about #sentiment indicator for $ARQL? The Short Ratio is 5% https://t.co/QTDv7y8XCy June 16th 2019, 8:06pm |
 |
@MogulAzam RT @jfais20: $ARQL has potential to really squeeze shorts banking on near term secondary offering or ¨sell the news¨ reaction- valuation st… June 16th 2019, 6:06pm |
 |
@BasselHabbal @jfais20 @semodough $arql Also, data tomorrow morning (premarket) from their phase 2 AKT inhibitor in Proteus syndrome. June 16th 2019, 6:06pm |
|
@portefeuillefun RT @semodough: LR $ARQL ARQL also reiterated that patients with Richter's transformation (RT) could present a fast-to-market pathway after… June 16th 2019, 5:06pm |
 |
@semodough LR $ARQL ARQL also reiterated that patients with Richter's transformation (RT) could present a fast-to-market pathw… https://t.co/5cwYeRmqgB June 16th 2019, 5:06pm |
 |
@BigWaveTrading Top Current Holding Update: $ARQL +32% in 1 1/2+ months. Signal: 4/29. Entry: 4/30 @ 6.34. I am splitting my three… https://t.co/9feGAe5wqa June 16th 2019, 5:06pm |
 |
@3TriggersTrader " $ARQL 352.BREAKOUT.STOP ,6:47 PM - 14 Jan 2019" by realtime trading @3TriggersTrader ...HOWTO? same as it ever wa… https://t.co/0Pa57Gu80D June 16th 2019, 4:06pm |
 |
@Gambiste1 RT @techwhitepapers: maybe as Acalabrutinib was developed to minimize off-target activity , $ARQL off target safety will be seen vividly ..… June 16th 2019, 4:06pm |
|
@Gambiste1 RT @MarekLiyanage: Nice recap by @inefficientmrkt on shorting $ARQL after the gap up in pre market on Friday. https://t.co/00HCfxEaqP June 16th 2019, 4:06pm |
|
@Gambiste1 RT @saar_eldar: $ARQL phase 1 trail results tomorrow / could be interesting https://t.co/HQ8S817cRr June 16th 2019, 4:06pm |
|
@Gambiste1 RT @goldmask123: @gcbioinv One thing you may notice on $arql poster is that they are now updosing all patient from previous cohorts to 65 m… June 16th 2019, 4:06pm |
|
@Gambiste1 RT @techwhitepapers: $ARQL 1 min chart from Friday . what I see here is a big gap on low volume followed by massive sells. massive. dont k… June 16th 2019, 4:06pm |
|
@MarketChmln $ARQL $ARQL upcoming event June 17: European Society of Human Genetics Conference. Options expiring on June 21 that… https://t.co/7DUMvXKLsF June 16th 2019, 3:06pm |
|
@Gambiste1 RT @goldmask123: @gcbioinv It's funny that the meeting organizer put three posters about BTKi together, $arql on one side and $snss on anot… June 16th 2019, 2:06pm |
 |
@saar_eldar $ARQL phase 1 trail results tomorrow / could be interesting https://t.co/HQ8S817cRr June 16th 2019, 1:06pm |
 |
@techwhitepapers $ARQL 1 min chart from Friday . what I see here is a big gap on low volume followed by massive sells. massive. don… https://t.co/kqmDE1rPhW June 16th 2019, 12:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.